TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

FDA Approval Summary: Amivantamab for the Treatment of Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations.

Katie Chon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.